Bibliography

Found 73 results
Filters: Keyword is HIV-1  [Clear All Filters]
2014
Vartak-Sharma N, Gelman B, Joshi C, Borgmann K, Ghorpade A. Astrocyte elevated gene-1 is a novel modulator of HIV-1-associated neuroinflammation via regulation of nuclear factor-κB signaling and excitatory amino acid transporter-2 repression. J Biol Chem. 2014 ;289(28):19599-612.
Zenón F, Segarra AC, Gonzalez M, Meléndez LM. Cocaine potentiates cathepsin B secretion and neuronal apoptosis from HIV-infected macrophages. J Neuroimmune Pharmacol. 2014 ;9(5):703-15.
Desplats P, Dumaop W, Cronin P, Gianella S, Woods SPaul, Letendre S, Smith DM, Masliah E, Grant I. Epigenetic alterations in the brain associated with HIV-1 infection and methamphetamine dependence. PLoS One. 2014 ;9(7):e102555.
Holder GE, McGary CM, Johnson EM, Zheng R, John VT, Sugimoto C, Kuroda MJ, Kim W-K. Expression of the mannose receptor CD206 in HIV and SIV encephalitis: a phenotypic switch of brain perivascular macrophages with virus infection. J Neuroimmune Pharmacol. 2014 ;9(5):716-26.
Gill AJ, Kovacsics CE, Cross SA, Vance PJ, Kolson LL, Jordan-Sciutto KL, Gelman B, Kolson DL. Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest. 2014 ;124(10):4459-72.
Kumar A, Ownby RL, Fernandez JB, Valdes-Sueiras M, Kumar M. HIV-1 in the Post Mortem Brain Regions in the post-cART era: Impact of Infection on Serotonin Status in Different Regions of Post Mortem Human Brain. 2014 .
Letendre S, Mills AM, Tashima KT, Thomas DA, Min SS, Chen S, Song IH, Piscitelli SC. ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects. Clin Infect Dis. 2014 ;59(7):1032-7.
Merali S, Barrero CA, Sacktor N, Haughey NJ, Datta PK, Langford D, Khalili K. Polyamines: Predictive Biomarker for HIV-Associated Neurocognitive Disorders. Journal of AIDS & Clinical Research. 2014 ;5(6).

Pages